Literature DB >> 19393695

An ultrasensitive rapid immunocytotoxicity assay for detecting Clostridium difficile toxins.

Xiangyun He1, Jufang Wang, Jennifer Steele, Xingmin Sun, Weijia Nie, Saul Tzipori, Hanping Feng.   

Abstract

We describe a novel ultrasensitive cell-based immunocytotoxicity assay for detecting Clostridium difficile toxin A and B. The assay is simple to perform with a turnaround time of approximately 3 h . It is particularly sensitive in detecting TcdA at a level less then 1 pg/ml. Using this assay, we were able to detect the presence of C. difficile toxins in the fecal and serum specimens of experimentally infected piglets.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19393695      PMCID: PMC2740367          DOI: 10.1016/j.mimet.2009.04.007

Source DB:  PubMed          Journal:  J Microbiol Methods        ISSN: 0167-7012            Impact factor:   2.363


  16 in total

Review 1.  Clostridium difficile testing: after 20 years, still challenging.

Authors:  Tracy D Wilkins; David M Lyerly
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

2.  Cytotoxicity assay in antibiotic-associated colitis.

Authors:  T W Chang; M Lauermann; J G Bartlett
Journal:  J Infect Dis       Date:  1979-11       Impact factor: 5.226

3.  A new multivalent B cell activation model--anti-IgD bound to Fc gamma RI: properties and comparison with CD40L-mediated activation.

Authors:  S Cho; D H Conrad
Journal:  Int Immunol       Date:  1997-02       Impact factor: 4.823

4.  Nosocomial acquisition of Clostridium difficile infection.

Authors:  L V McFarland; M E Mulligan; R Y Kwok; W E Stamm
Journal:  N Engl J Med       Date:  1989-01-26       Impact factor: 91.245

5.  Clostridium difficile-associated diseases. The clinical courses of 18 fatal cases.

Authors:  M Siemann; M Koch-Dörfler; G Rabenhorst
Journal:  Intensive Care Med       Date:  2000-04       Impact factor: 17.440

6.  Identification of Clostridium difficile toxin B cardiotoxicity using a zebrafish embryo model of intoxication.

Authors:  Elaine E Hamm; Daniel E Voth; Jimmy D Ballard
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-11       Impact factor: 11.205

Review 7.  Clostridium difficile infection.

Authors:  C P Kelly; J T LaMont
Journal:  Annu Rev Med       Date:  1998       Impact factor: 13.739

8.  Label-free, real-time monitoring of IgE-mediated mast cell activation on microelectronic cell sensor arrays.

Authors:  Yama A Abassi; Jo Ann Jackson; Jenny Zhu; James O'Connell; Xiaobo Wang; Xiao Xu
Journal:  J Immunol Methods       Date:  2004-09       Impact factor: 2.303

9.  Establishment of gastric Campylobacter pylori infection in the neonatal gnotobiotic piglet.

Authors:  S Krakowka; D R Morgan; W G Kraft; R D Leunk
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

10.  Antibody-enhanced, Fc gamma receptor-mediated endocytosis of Clostridium difficile toxin A.

Authors:  Xiangyun He; Xingmin Sun; Jufang Wang; Xiaoning Wang; Quanshun Zhang; Saul Tzipori; Hanping Feng
Journal:  Infect Immun       Date:  2009-03-23       Impact factor: 3.441

View more
  28 in total

1.  Systemic dissemination of Clostridium difficile toxins A and B is associated with severe, fatal disease in animal models.

Authors:  Jennifer Steele; Kevin Chen; Xingmin Sun; Yongrong Zhang; Haiying Wang; Saul Tzipori; Hanping Feng
Journal:  J Infect Dis       Date:  2011-12-05       Impact factor: 5.226

2.  Assessment of Clostridium difficile infections by quantitative detection of tcdB toxin by use of a real-time cell analysis system.

Authors:  Alex B Ryder; Ying Huang; Haijing Li; Min Zheng; Xiaobo Wang; Charles W Stratton; Xiao Xu; Yi-Wei Tang
Journal:  J Clin Microbiol       Date:  2010-08-18       Impact factor: 5.948

3.  A novel multivalent, single-domain antibody targeting TcdA and TcdB prevents fulminant Clostridium difficile infection in mice.

Authors:  Zhiyong Yang; Diane Schmidt; Weilong Liu; Shan Li; Lianfa Shi; Jinliang Sheng; Kevin Chen; Hua Yu; Jacqueline M Tremblay; Xinhua Chen; Kurt H Piepenbrink; Eric J Sundberg; Ciaran P Kelly; Guang Bai; Charles B Shoemaker; Hanping Feng
Journal:  J Infect Dis       Date:  2014-03-27       Impact factor: 5.226

4.  Masking autoprocessing of Clostridium difficile toxin A by the C-terminus combined repetitive oligo peptides.

Authors:  Yongrong Zhang; Therwa Hamza; Si Gao; Hanping Feng
Journal:  Biochem Biophys Res Commun       Date:  2015-02-26       Impact factor: 3.575

Review 5.  Ultrasensitive Detection and Quantification of Toxins for Optimized Diagnosis of Clostridium difficile Infection.

Authors:  Nira R Pollock
Journal:  J Clin Microbiol       Date:  2015-12-09       Impact factor: 5.948

6.  Critical roles of Clostridium difficile toxin B enzymatic activities in pathogenesis.

Authors:  Shan Li; Lianfa Shi; Zhiyong Yang; Yongrong Zhang; Gregorio Perez-Cordon; Tuxiong Huang; Jeremy Ramsey; Numan Oezguen; Tor C Savidge; Hanping Feng
Journal:  Infect Immun       Date:  2014-11-17       Impact factor: 3.441

7.  MBX-500 is effective for treatment of Clostridium difficile infection in gnotobiotic piglets.

Authors:  Jennifer Steele; Quanshun Zhang; Gillian Beamer; Michelle Butler; Terry Bowlin; Saul Tzipori
Journal:  Antimicrob Agents Chemother       Date:  2013-05-20       Impact factor: 5.191

Review 8.  Antibodies for treatment of Clostridium difficile infection.

Authors:  David P Humphreys; Mark H Wilcox
Journal:  Clin Vaccine Immunol       Date:  2014-04-30

9.  Quantitative detection of Vibrio cholera toxin by real-time and dynamic cytotoxicity monitoring.

Authors:  Dazhi Jin; Yun Luo; Min Zheng; Haijing Li; Jing Zhang; Melinda Stampfl; Xiao Xu; Gangqiang Ding; Yanjun Zhang; Yi-Wei Tang
Journal:  J Clin Microbiol       Date:  2013-09-18       Impact factor: 5.948

10.  Mechanisms of protection against Clostridium difficile infection by the monoclonal antitoxin antibodies actoxumab and bezlotoxumab.

Authors:  Zhiyong Yang; Jeremy Ramsey; Therwa Hamza; Yongrong Zhang; Shan Li; Harris G Yfantis; Dong Lee; Lorraine D Hernandez; Wolfgang Seghezzi; Jamie M Furneisen; Nicole M Davis; Alex G Therien; Hanping Feng
Journal:  Infect Immun       Date:  2014-12-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.